Screening compound: C22H30N4O3 (M284-0314)

Screening compound: C<sub>22</sub>H<sub>30</sub>N<sub>4</sub>O<sub>3</sub> (M284-0314)
Screening compound: C<sub>22</sub>H<sub>30</sub>N<sub>4</sub>O<sub>3</sub> (M284-0314) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C22H30N4O3 (M284-0314)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M284-0314

Molecular Formula

C22H30N4O3 (C22 H30 N4 O3)

Compound Name

10-[2-(4-isopropylpiperazino)-2-oxoethyl]-7-methyl-2,3-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione

IUPAC name

13-methyl-9-{2-oxo-2-[4-(propan-2-yl)piperazin-1-yl]ethyl}-39-diazatricyclo[8.4.0.0^{37}]tetradeca-1(14)1012-triene-28-dione

SMILES

CC(C)N(CC1)CCN1C(CN(c(ccc(C)c1)c1C(N1C2CCC1)=O)C2=O)=O

InChI

InChI=1S/C22H30N4O3/c1-15(2)23-9-11-24(12-10-23)20(27)14-26-18-7-6-16(3)13-17(18)21(28)25-8-4-5-19(25)22(26)29/h6-7,13,15,19H,4-5,8-12,14H2,1-3H3/t19-/m0/s1

InChI Key

CEZGLXNKONXKGK-IBGZPJMESA-N

MDL Number (MFCD)

MFCD27535030

C22H30N4O3 (M284-0314) in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Hsp90-Targeted Library (11355 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Targeted Diversity Library (40567 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epigenetics Focused Set (26518 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with C22H30N4O3 (M284-0314) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C22H30N4O3 (M284-0314)?
Check Price and Availability of C22H30N4O3 (M284-0314), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C22H30N4O3 (M284-0314) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C22H30N4O3 (M284-0314)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C22H30N4O3 (M284-0314)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C22H30N4O3 (M284-0314) available by request